Work

Bortezomib (BTZ) prior to and as maintenance therapy after autologous stem cell transplant (ASCT) in multiple myeloma (MM): Long-term follow-up of a phase II study

Year: 2007
Type: conference-abstract
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2259941359
Cites:
Cited by: 1
Related to: 10